SCHEMBL38314

SCHEMBL38314

NCCSc1ccc([C](c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
MAPK1 P28482 1/20 0.46
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
RECQL P46063 1/20 0.42
CYP1A2 P05177 4/20 0.41
CYP2C19 P33261 4/20 0.41
CYP3A4 P08684 3/20 0.41
CYP2D6 P10635 3/20 0.41
CYP2C9 P11712 2/20 0.41
TSHR P16473 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
HPGD P15428 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KIF11 P52732 6/20 0.40
HDAC1 Q13547 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11299425 0.85 ALDH1A1 (0.50) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL376816 0.81 ALDH1A1 (0.70) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL3671919 0.79 ALDH1A1 (0.67) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
Bromide SCHEMBL11192119 0.79 ALDH1A1 (0.67) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL15053055 0.79 MCL1 (0.38) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL3667550 0.78 ALDH1A1 (0.48) ALDH1A1MAPK1NPC1RAB9ACYP1A2
Hydrochloric Acid SCHEMBL28033163 0.77 TSHR (0.46) ALDH1A1NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL11266685 0.75 ALDH1A1 (0.50) ALDH1A1NPC1RAB9ASMN1; SMN2RECQL
Phosphoric Acid SCHEMBL11703957 0.74 ALDH1A1 (0.54) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL38313 0.74 RAB9A (0.44) ALDH1A1NPC1RAB9ACYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9023957-B2 Compound for use in peptide synthesis NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2015-05-05 US disclosed
US-20130131286-A1 COMPOUND FOR USE IN PEPTIDE SYNTHESIS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2013-05-23 US disclosed
EP-2590939-A1 COMPOUND FOR USE IN PEPTIDE SYNTHESIS Nanyang Technological University (SG) 2013-05-15 EP disclosed
WO-2012005691-A1 COMPOUND FOR USE IN PEPTIDE SYNTHESIS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2012-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131286-A1 COMPOUND FOR USE IN PEPTIDE SYNTHESIS PTMS, ANPEP, BCAT2 ALDH1A1 4346/4885MAPK1 3468/4885NPC1 1685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.